How should I manage a 19‑year‑old female with recent viral upper‑respiratory symptoms and a respiratory culture growing Enterobacter cloacae complex that is resistant to amoxicillin‑clavulanate and cefoxitin but susceptible to cefepime, ertapenem, gentamicin, levofloxacin, tetracycline, tobramycin, and trimethoprim‑sulfamethoxazole?

No Treatment Indicated for Asymptomatic Colonization

You should not treat this patient with antibiotics. The Enterobacter cloacae complex isolated from an upper respiratory culture represents colonization, not infection, in a patient who had viral upper respiratory symptoms 12 days ago.

Clinical Reasoning

Why This is Colonization, Not Infection

• Timing is critical: The patient was seen 12 days ago with viral symptoms (COVID, flu, and strep all negative)
• Source matters: Upper respiratory cultures routinely grow colonizing bacteria, not pathogens
• Clinical context: She had viral upper respiratory symptoms—there's no indication she had bacterial pneumonia, sinusitis requiring treatment, or any ongoing bacterial infection
• Current status unknown: You don't mention if she's still symptomatic now, 12 days later

The Evidence Against Treatment

The COVID-19 era guidelines on bacterial co-infections are directly applicable here. Bacterial co-infections in viral respiratory illness occur in only 3.5% of cases at presentation 1. The guidelines emphasize restrictive antibiotic use and recommend against empirical antibiotics unless there is high clinical suspicion of bacterial co-infection with radiological findings and/or inflammatory markers compatible with bacterial infection 1.

Common pitfall: Treating positive respiratory cultures without clinical correlation leads to unnecessary antibiotic exposure, selection for resistance, and potential adverse effects.

What You Should Do Instead

Immediate Actions

1. Contact the patient to assess her current clinical status:

   • Is she still symptomatic?
   • Has she improved since the visit 12 days ago?
   • Any new or worsening symptoms (fever, productive cough, dyspnea, chest pain)?

2. If she's asymptomatic or improved: No treatment needed. This confirms the culture represents colonization.

3. If she remains symptomatic or worsened: Reassess clinically with:

   • Physical examination
   • Consider chest X-ray if lower respiratory symptoms
   • Inflammatory markers (CRP, procalcitonin) if considering bacterial infection
   • Blood cultures if systemic infection suspected

If True Bacterial Infection is Present

Only if clinical reassessment reveals actual bacterial infection (not just a positive culture), treatment options based on susceptibilities would include 2:

• Levofloxacin 750 mg daily (oral, excellent bioavailability, susceptible)
• Trimethoprim-sulfamethoxazole DS twice daily (oral, susceptible)
• Cefepime or Ertapenem (IV options if severe, both susceptible) 3

Critical Warning About Enterobacter

The culture report correctly notes that Enterobacter cloacae complex can develop resistance during therapy with third-generation cephalosporins due to inducible AmpC β-lactamase 4, 5. This is why cefepime (4th generation) or carbapenems are preferred for serious infections, and why you should avoid cefpodoxime despite in vitro susceptibility for any significant infection.

Key Takeaway

Positive cultures without clinical infection should not be treated. Upper respiratory tract cultures frequently grow colonizing organisms. The patient had a viral illness 12 days ago—treating colonization now would be inappropriate antibiotic stewardship, expose her to unnecessary risks (including C. difficile), and select for resistant organisms. Call the patient to assess her current status before making any treatment decisions.